
CSRC erteilt Medtide Inc. eine Filing Notice für H-Aktien-Umlaufantrag

I'm PortAI, I can summarize articles.
Medtide Inc. has received a Filing Notice from the China Securities Regulatory Commission (CSRC) regarding the completion of the regulatory review for its application to fully convert its H-shares. The conversion and listing are subject to further procedures by the CSRC, the Hong Kong Stock Exchange, and other relevant authorities.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

